secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001193125-25-189435
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma announces three director resignations, appoints Sarah Reed
------------------------------------------------------------------------

- Joshua Resnick, Matthew Patterson, and David Lubner resigned from the Board effective Aug 25-26, 2025; no disagreement cited.
- Sarah Reed, General Counsel of RA Capital Management, appointed as independent Class II director effective Aug 27.
- Reed receives standard compensation: $40k cash retainer, option to purchase 60k shares, and annual option grants.
- Appointment was per securities purchase agreement with RA Capital, which holds >5% of VOR voting stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525189435/0001193125-25-189435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525189435/d939901d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-189435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer